The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Hodges Mauri K since 2010.
The trader's CIK number is 1489773.
At the time of the last reporting, Hodges Mauri K was the VP Finance & Controller of Catalyst Biosciences, Inc.. (stock ticker symbol CBIO).
Also see all insider trading activities at Catalyst Biosciences, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2011 | TRGT | 0 | $0 | 19,933 | $600,048 | 19,933 | $110,627 |
| 2010 | TRGT | 0 | $0 | 12,902 | $323,855 | 12,902 | $109,796 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2011-03-09 | TRGT | Option Ex | 1,500 | 5.55 | 8,325 |
| 2011-03-09 | TRGT | Sale | 1,500 | 30.00 | 45,000 |
| 2011-03-03 | TRGT | Option Ex | 5,030 | 5.55 | 27,916 |
| 2011-03-03 | TRGT | Sale | 5,030 | 30.00 | 150,900 |
| 2011-03-07 | TRGT | Option Ex | 500 | 5.55 | 2,775 |
| 2011-03-07 | TRGT | Sale | 500 | 30.00 | 15,001 |
| 2011-03-02 | TRGT | Option Ex | 200 | 5.55 | 1,110 |
| 2011-03-01 | TRGT | Sale | 12,703 | 30.16 | 383,147 |
| 2011-03-02 | TRGT | Sale | 200 | 30.00 | 6,000 |
| 2011-03-01 | TRGT | Option Ex | 12,703 | 5.55 | 70,501 |
| 2010-12-16 | TRGT | Option Ex | 2,700 | 8.51 | 22,977 |
| 2010-12-16 | TRGT | Sale | 2,700 | 25.24 | 68,142 |
| 2010-11-03 | TRGT | Option Ex | 1,000 | 8.51 | 8,510 |
| 2010-11-04 | TRGT | Option Ex | 7,800 | 8.51 | 66,378 |
| 2010-11-03 | TRGT | Sale | 1,000 | 25.05 | 25,055 |
| 2010-11-04 | TRGT | Sale | 7,800 | 25.08 | 195,608 |
| 2010-05-13 | TRGT | Sale | 1,402 | 25.00 | 35,050 |
| 2010-05-13 | TRGT | Option Ex | 1,402 | 8.51 | 11,931 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Hodges Mauri K (VP Finance & Controller of Catalyst Biosciences, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.